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Comparative genome analysis revealed seven uncharacterized genes, sven0909 to sven0915, adjacent to the previously identified
chloramphenicol biosynthetic gene cluster (sven0916–sven0928) of Streptomyces venezuelae strain ATCC 10712 that was absent
in a closely related Streptomyces strain that does not produce chloramphenicol. Transcriptional analysis suggested that three of
these genes might be involved in chloramphenicol production, a prediction confirmed by the construction of deletion mutants.
These three genes encode a cluster-associated transcriptional activator (Sven0913), a phosphopantetheinyl transferase
(Sven0914), and a Na/H antiporter (Sven0915). Bioinformatic analysis also revealed the presence of a previously undetected
gene, sven0925, embedded within the chloramphenicol biosynthetic gene cluster that appears to encode an acyl carrier protein,
bringing the number of new genes likely to be involved in chloramphenicol production to four. Microarray experiments and
synteny comparisons also suggest that sven0929 is part of the biosynthetic gene cluster. This has allowed us to propose an up-
dated and revised version of the chloramphenicol biosynthetic pathway.
Chloramphenicol (CHL) is a bacteriostatic antibiotic that in-hibits protein synthesis by binding to the 50S subunit of the
bacterial ribosome. It is active against both Gram-negative and
Gram-positive bacteria, including many multiply drug-resistant
strains. CHL is produced by several Gram-positive soil actinomy-
cetes, but its biosynthesis has been analyzed mostly in Streptomy-
ces venezuelae strain ATCC 10712 (1). The initial stages of CHL
biosynthesis utilize the shikimate pathway that leads to the pro-
duction of chorismic acid. Chorismic acid serves as a branch point
for aromatic amino acid (phenylalanine, tyrosine, and trypto-
phan) biosynthesis and for the production of p-aminobenzoic
acid (PABA) that is required for folic acid biosynthesis (2). The
conversion of chorismic acid to PABA occurs via 4-amino-4-de-
oxychorismate the precursor for the pathway dedicated to chlor-
amphenicol biosynthesis (3).
Previous analyses of the CHL biosynthetic gene cluster of S.
venezuelae resulted in the identification of 12 genes with a proven
or likely role in CHL production (3–10). For reasons that we do
not understand, we were unable to detect CHL production by S.
venezuelae under our laboratory conditions, but we did succeed in
expressing the CHL biosynthetic gene cluster from this strain in
the heterologous host Streptomyces coelicolor A3 (2, 11).
Bioinformatic analysis has become a powerful tool for the
identification of natural product biosynthetic gene clusters (12,
13). By combining comparative genomics with microarray and
bioinformatic analyses, we have identified four additional genes
likely to be involved in CHL production, and we confirmed the
participation of three of these in antibiotic biosynthesis by muta-
tional analyses.
MATERIALS AND METHODS
Strains andgeneralmethods.The strains used and generated in this study
are listed in Table 1. Escherichia coli strains were grown and manipulated
according to standard methods (14–16). S. coelicolor and S. venezuelae
strains were grown as described previously on soya flour mannitol (SFM)
or DNA agar medium (17) and in glucose-yeast extract-malt extract
(GYM) (18) or in maltose-yeast extract-malt extract (MYM) (19) liquid
medium. The plasmids and oligonucleotides used are described in Table 2
and Table S1 in the supplemental material, respectively.
Construction of deletionmutants.Genes carried by pAH91 (Andrew
Hesketh, personal communication; Gomez-Escribano and Bibb [11])
were replaced either individually (sven0913, sven0914, and sven0915) or in
groups (sven0909 to sven0912 and sven0913–sven0915) with a hygromycin
(HYG) resistance cassette amplified from pIJ10700 using the primer pairs
listed in Table S1 in the supplemental material, as described by Gust et al.
(15). Themutationswere confirmed by PCRusing flanking primers. Con-
jugations between E. coli strain ET12567 with plasmid pUZ8002 carrying
the oriT-containing pAH91 derivatives and streptomycete strains were
carried out as described previously (17).
Complementation of deletion mutants. To complement the sven0913,
sven0914, and sven0915 deletion mutants, PCR products were generated
by high-fidelity PCR using the primers listed in Table S1 in the supple-
mental material. For the complementation of sven0913 and sven0915,
the PCR products extended from the beginning of the upstream inter-
genic region to the stop codon of each gene. The fragments were cloned
into pRT802 (20) to generate pIJ12745 and pIJ12748, respectively, which
were then transferred into the corresponding mutant strains using E. coli
strain DH10B transformed with either of the plasmids in triparental mat-
ings with E. coli TOP10 (Invitrogen) containing the driver plasmid
pR9406 and the nonmethylating E. coli strain ET12567, according to stan-
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dard procedures (17). For the complementation ofsven0914, the coding
sequence between the start and stop codons of the gene was amplified and
cloned into pIJ12551 (21) to fuse sven0914 to the constitutive ermE* pro-
moter generating pIJ12746. ABamHI fragment frompIJ12746 containing
ermE*p-sven0914 was then cloned into pRT802 to generate pIJ12747,
which was manipulated as above.
Overexpression of sven0913. A PCR product containing sven0913
(extending from the start to stop codons) was generated by high-fidelity
PCR using the primers listed in Table S1 in the supplemental material.
This fragment was cloned into the integrative vector pIJ10257 (22) to fuse
sven0913 to the constitutive ermE* promoter, generating pIJ12744. The
vector was transferred into S. venezuelae by conjugation from E. coli
ET12567(pUZ8002), as described previously (17).
HPLCanalysis.Chloramphenicol productionwas quantified by high-
performance liquid chromatography (HPLC). The culture supernatants
were filtered through VectaSpin Micro polysulfone 0.2-mm columns
(Whatman, Maidstone, United Kingdom), injected onto a Spherisorb
5-mm ODS2 4.6 by 250 mm C18 column (Waters, Milford, MA, USA)
fitted to an Agilent 1100 HPLC system with a diode array detector and
analyzed using a methodmodified fromHe et al. (4; A. Hesketh, personal
communication): gradient water-methanol; min 0, 0% methanol; min 2,
25%methanol; min 12, 50%methanol, min 14, 100%methanol; min 20,
100%methanol; andmin 22, 0%methanol. CHL eluted at about 15.8min
andwas detected at 273 nm.CHL (catalog no. C03478; Sigma)was used as
a standard.
DNAmicroarray analysis.RNA isolation from S. venezuelae and sub-
sequentDNAmicroarray analysis were carried out as described previously
(23).
Real-time PCR analysis. Streptomyces strains were cultured in liquid
GYM medium in triplicate, as described previously (17). RNA was ex-
tracted according to published procedures (24) from 2.5 ml of culture
sampled after 16 h of growth of the S. venezuelae strains and after 48 h of
growth of the S. coelicolorM1152 derivatives. Mycelial pellets were resus-
pended in 1 ml of RTL buffer with lysing matrix B (MP Biomedicals) and
homogenized using a FastPrep instrument (BIO 101). Two pulses of 30 s
of intensity 6.0 were applied, with cooling down for 1 min on ice between
TABLE 1 Strains used and constructed in this study
Strain Genotype
Reference
or source
E. coli BW25113 K-12 derivative (araBAD rhaBAD) carrying plasmid pIJ790 40
E. coli DH5 F 80dlacZM15 (lacZYA-argF) U169 recA1 endA1 hsdR17 (rK
mK
) phoA
supE44 thi-1 gyrA96 relA1 )
41
E. coli ET12567 dam-13:: Tn9 dcm-6 hsdM CHLr, carrying helper plasmid pUZ8002 42
E. coli TOP10 DH10B derivative Invitrogen
M. luteus ATCC 4698 Bioassay indicator microorganism ATCC
S. coelicolorM1152 M145 derivative act red cpk cda rpoB(C1298T) 11
S. coelicolorM1581 M1152 containing cosmid pAH91 (S. venezuelae cosmid containing CHL cluster) This work
S. coelicolorM1583 M1152 pAH91 (sven0909–sven0912) This work
S. coelicolorM1584 M1152 pAH91 (sven0913–sven0915) This work
S. coelicolorM1585 M1152 pAH91 (sven0913) This work
S. coelicolorM1586 M1152 pAH91 (sven0914) This work
S. coelicolorM1587 M1152 pAH91 (sven0915) This work
S. coelicolorM1588 M1152 pAH91 (sven0913) pIJ12745 This work
S. coelicolorM1589 M1152 pAH91 (sven0914) pIJ12747 This work
S. coelicolorM1590 M1152 pAH91 (sven0915) pIJ12748 This work
S. venezuelae ATCC 10712 Wild-type S. venezuelae strain ATCC
S. venezuelaeM1582 S. venezuelae with pIJ12744 (ermE*p::sven0915) This work
S. venezuelaeM1591 S. venezuelae with pIJ10257 This work
TABLE 2 Vectors and constructs used in this study
Vector/construct Descriptiona Reference or source
pAH91 Conjugative and integrative (C31 attB) derivative of cosmid 4P22 containing the CHL
gene cluster from S. venezuelae, APRr CARr
11
pIJ10700 pBluescript II KS() containing hyg-oriT cassette 16
pUZ8002 tra, neo, RP4 43
pIJ790 -RED (gam, bet, exo), cat, araC, rep101ts 44
pR9406 Driver plasmid, CARr derived from pUB307 45; David Figurski,
personal communication
pIJ10257 oriT, BT1 attB-int, HYGr, ermE*p 22
pIJ12744 pIJ10257 with sven0913, HYGr This work
pRT802 Conjugative and BT1-integrative vector, KANr 20
pIJ12551 Conjugative and C31-integrative vector, APRr 21
pIJ12744 pIJ10257 with sven0913 under ermE*p control, HYGr This work
pIJ12745 pRT802 with sven0913 and its promoter region, KANr This work
pIJ12746 pIJ12551 with sven0914 under ermE*p control, APRr This work
pIJ12747 pRT802 with sven0914 under ermE*p control, KANr This work
pIJ12748 pRT802 with sven0915 and its promoter region, KANr This work
a APRr, apramycin resistance; CARr, carbenicillin resistance; HYGr, hygromycin resistance; KANr, kanamycin resistance.
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pulses. The supernatants were centrifuged for 10 min at 13,000 rpm and
then treated according to the instructions given in theRNeasy kit (Qiagen,
Crawley, United Kingdom). The RNA samples were treated with DNase I
(Invitrogen) until they were free of DNA contamination. The RNA was
quantified, and equal amounts from each sample were converted to
cDNA, according to the manufacturer’s instructions (SuperScript; Invit-
rogen). The oligonucleotide pairs listed in Table S1 in the supplemental
material were used to amplify the genes representing each of the putative
operons within the CHL biosynthetic cluster, as well as the left and right
flanking genes (sven0912 and sven0930, respectively). Amplification was
also attempted using the same oligonucleotide pairs on RNA samples that
had not been treated with reverse transcriptase to confirm a lack of DNA
contamination.
RESULTS
Comparative genome and microarray analyses reveal three pu-
tative newmembers of the chloramphenicol gene cluster.Com-
parative genome analysis can play an extremely useful role in iden-
tifying and determining the extent of natural product biosynthetic
gene clusters. The genome mining of Streptomyces sp. strain OH-
4156 (25), which does not produce CHL, indicated a high level of
nucleotide sequence similarity with the genome of S. venezuelae.
The alignment of the Streptomyces sp. strainOH-4156 Solexa con-
tigs on the S. venezuelae genome sequence in the region of theCHL
biosynthetic gene cluster revealed the presence of seven genes
(sven0909–sven0915) adjacent to the previously identified CHL
biosynthetic gene cluster (sven0916–sven0928) that were absent in
the nonproducing strain (Fig. 1A). To gain insight into whether
any of these newly identified genes might play a role in CHL pro-
duction, we compared their transcriptional profiles with those of
established CHL biosynthetic genes in the microarray data from
submerged cultures of S. venezuelae and several of its developmen-
tal mutants that are deficient in sporulation. Although we were
unable to detect CHL biosynthesis in S. venezuelae, the transcrip-
tion of sven0916–sven0928was detected in the wild-type strain at a
low level, peaking at 14 h of cultivation (Fig. 1B). Surprisingly, the
transcription of these genes was markedly increased in a bldM
mutant and showed a pattern of expression similar to that in the
wild-type strain, but peaking after 16 h of cultivation (Fig. 1B).
Analysis of the expression profiles for sven0909–sven0915 sug-
gested that three of these genes, sven0913–sven0915, might be co-
ordinately regulated with sven0916–sven0928, genes known or be-
lieved to be involved in chloramphenicol biosynthesis, and which
thus might form part of an extended CHL biosynthetic gene clus-
FIG 1 (A) Alignment of Solexa contigs (shown as filled blue arrows) from the draft genome sequence of Streptomyces sp. strain OH-4156 with the region of the
S. venezuelae genome encoding CHL biosynthesis (protein-coding sequences are shown as filled green arrows). A Solexa contig was aligned to the S. venezuelae
genome sequence if it exhibited80% identity over a length of100 nucleotides (average level of nucleotide sequence identity between the Solexa contigs and
the S. venezuelae genome sequencewas 88.5%,with amodal value of 93%). The alignment shows a cluster of 21 genes (sven0909–sven0929) unique to S. venezuelae
that includes the 12 previously implicated in CHL biosynthesis (sven0916–sven0928, shown in the green rectangle). (B) Microarray expression profiles of the 21
genes suggested that sven0913–sven0929may be transcriptionally coregulated. The x axis represents culture age, and the y axis is normalized transcript abundance
on a log2 scale.
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ter (Fig. 1B). These three genes were predicted to encode a tran-
scriptional activator (sven0913) with 44% amino acid sequence
identity to StrR, the pathway-specific activator of the streptomy-
cin biosynthetic gene cluster in Streptomyces griseus, a phospho-
pantetheinyl transferase (PPTase) (sven0914), and a Na/H an-
tiporter (sven0913). In contrast, the expression patterns of
sven0909–sven0912, all encoding hypothetical proteins, were dif-
ferent from those of the known CHL biosynthetic genes, suggest-
ing that they may not be part of the CHL cluster (Fig. 1B).
Deletion of sven0913–sven0915 abolishes CHL production.
To assesswhether sven0909–sven0912 and sven0913–sven0915play
a role in CHL biosynthesis, each set of genes was deleted from the
clonedCHL biosynthetic gene cluster of pAH91 by PCR targeting.
The HYG resistance cassette from pIJ10700 (15) was used to re-
place sven0909–sven0912 (sven0909–sven0912) and sven0913–
sven0915 (sven0913–sven0915) in E. coli, and the mutated cos-
mids were transferred to S. coelicolor M1152 by conjugation,
yieldingM1583 (sven0909–sven0912) andM1584 (sven0913–
sven0915), respectively. The integration of each cosmidwas con-
firmed by PCR. The two strains, together with S. coelicolorM1152
carrying pAH91 (M1581), were grown in GYM liquid medium
(18), and the supernatants from each culture were spotted onto
filter paper discs laid on top of a lawnofMicrococcus luteus (Fig. 2).
While the supernatant fromM1583 (sven0909–sven0912,1 in
Fig. 2) produced a zone of inhibition identical to that of M1581,
that fromM1584 (sven0913–sven0915,2 in Fig. 2) showed no
inhibitory activity, and HPLC analysis confirmed the absence of
CHL in the supernatant (data not shown), indicating that at least
one of the genes sven0913–sven0915 plays an essential role in CHL
biosynthesis.
Individual deletion of sven0913, sven0914, and sven0915
confirms their role in CHL production. To investigate the indi-
vidual roles of sven0913–sven0915 in CHL biosynthesis, PCR tar-
geting was carried out on pAH91 to separately delete each gene.
The deletion of sven0913 (yieldingM1585), the putative transcrip-
tional activator, abolished antibiotic activity (Fig. 3A) and CHL
production (Fig. 3B). In contrast, the deletion of either sven0914
(to giveM1586), coding for a putative PPTase, or sven0915 (yield-
ing M1587), encoding a putative Na/H antiporter, decreased
the level of CHL production to around 40% of that observed with
the wild-type gene cluster. Presumably, the roles that Sven0914
and Sven0915 play in CHL biosynthesis can be at least partially
substituted by proteins encoded elsewhere in the S. coelicolor ge-
nome.
The complementation of each of the three mutant strains was
accomplished using integrative vectors containing the gene of in-
terest expressed from either its native promoter (sven0913 and
sven0915) or from the constitutive ermE* promoter (sven0914). In
each case, CHL productionwas restored to the level observedwith
the wild-type gene cluster (Fig. 3).
Constitutive expression of sven0913 activates CHL produc-
tion in S. venezuelae.Asmentioned previously, wewere unable to
detect chloramphenicol production in S. venezuelae under a vari-
ety of growth conditions (Fig. 4). Since our results suggest that
sven0913 likely acts as a transcriptional activator of the CHL bio-
synthetic gene cluster, we attempted to overexpress this gene in S.
venezuelae. To achieve this, the sven0913 coding sequence was
cloned in the integrative vector pIJ10257 (22) under the control of
the constitutive ermE* promoter, and the resulting plasmid was
transferred to S. venezuelae by conjugation and integration con-
firmed by PCR, yielding M1582. The supernatants obtained from
this strain and from wild-type S. venezuelae were analyzed by
HPLC forCHLproduction (Fig. 4). The constitutive expression of
sven0913 led to CHL production levels of approximately 3.5
g/ml after 72 h of growth of M1582, while CHL biosynthesis
remained undetectable in the vector-only control strain (M1591),
FIG 2 Analysis of the effect on CHL biosynthesis of replacing sven0909–
sven0912 or sven0913–sven0915 with the hyg cassette from pIJ10700. S. coeli-
color M1581 and its mutant derivatives M1583 (1 for sven0909–sven0912)
and M1584 (2 for sven0913–sven0915) were grown for 6 days in GYM liquid
medium, and 100 l of culture supernatant was assayed for antibiotic activity
againstM. luteus. The absence of an inhibition zone in the2mutant indicates
an essential role for at least one of the sven0913–sven0915 genes in CHL bio-
synthesis.
FIG 3 Analysis of the effects of single-gene deletions on CHL production. S. coelicolor M1581 and its mutant derivatives M1585 (sven0913 [13]), M1586
(sven0914 [14]), and M1587 (sven0915 [15]) and their complemented derivatives (Comp13, Comp14, and Comp15, respectively) were grown for 5 days
in GYM liquid medium. (A) One hundred microliters of supernatant from each of the cultures was assayed for antibiotic activity against M. luteus. (B)
Quantitation of CHL production by each of the strains by HPLC analysis. Bars indicate the standard deviation for three biological samples.
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consistent with the proposed role of sven0913 as a cluster-situated
transcriptional activator of the CHL biosynthetic gene cluster.
RT-PCR analyses confirm that Sven0913 is a transcriptional
activator of the CHL biosynthetic cluster. To confirm that
sven0913 plays a role in activating transcription of the CHL bio-
synthetic gene cluster, real-time PCR (RT-PCR) analysis was per-
formed on the following strains: wild-type S. venezuelae, M1582
(S. venezuelae with constitutive expression of sven0913), M1581
(S. coelicolor M1152 carrying pAH91), and M1585 (M1581 with
sven0913 deleted). RNA was extracted from each of the cultures
and RT-PCR conducted using primers amplifying the transcripts
from several regions of the CHL gene cluster as well as from flank-
ing genes (see Table S1 in the supplemental material). While the
constitutive expression of sven0913 in S. venezuelae resulted in
elevated levels of expression of the genes predicted to lie within the
CHL gene cluster, it had no effect on the flanking genes sven0912
and sven0930 (Fig. 5). Conversely, the deletion of sven0913 in S.
coelicolor (M1585) reduced the levels of expression of the pre-
dicted CHL biosynthetic genes but had no effect on those of the
flanking genes. These results confirm that Sven0913 is a previously
unidentified transcriptional activator that plays a crucial role in
the regulation of CHL biosynthesis.
sven0925, a previously unidentified gene encoding a putative
acyl carrier protein. Our earlier annotation of the genome se-
quence of S. venezuelae (GenBank accession no. FR845719) had
identified an additional previously undetected gene in the CHL
biosynthetic gene cluster, sven0925, whose 108-amino-acid prod-
uct failed to show clear similarity to the proteins of known func-
tion in theNCBI database. Amore recent BLASTp search revealed
a large number of homologues present in the genome sequences,
some of which were annotated as acyl carrier proteins (ACPs).
Based on this observation, Sven0925 was subjected to analysis us-
ing the Phyre2 protein structure prediction server (26) (http:
//www.sbg.bio.ic.ac.uk/phyre2). The program predicts with 97%
to 98% confidence that Sven0925 is a homologue of structurally
characterized ACPs from a variety of bacterial species; for exam-
ple, 77 residues of Sven0925 (71% of its sequence) were modeled
with 98.0% confidence to the structure of the holo-acyl carrier
protein ne2163 from Nitrosomonas europaea (see Fig. S1 in the
supplemental material). Moreover, Sven0925 possesses a con-
served serine at position 50 that is predicted to be the catalytic
residue needed for the addition of the 4=-phosphopantetheine
moiety required for the activity of the holo-ACP (see Fig. S2 in the
supplemental material). Together with the expression profile of
sven0925, which conforms to that of the other CHL biosynthetic
genes, we conclude that Sven0925 is indeed an ACP involved in
CHL biosynthesis (see Fig. 6).
sven0929, part of the CHL biosynthetic gene cluster, but not
required for CHL production. Synteny comparisons of sven-
0900–sven0940 with the draft genome sequences of both Strepto-
myces sp. strain OH-4156 (Fig. 1A) andMicromonospora carbona-
cea strain ATCC 39149 (see below; see also Fig. S3 in the
supplemental material) suggested that sven0929 might be part of
the CHLbiosynthetic gene cluster. This inferencewas further sup-
ported by the microarray analysis (Fig. 1B) and RT-PCR experi-
FIG 4 CHL production in wild-type (WT) S. venezuelae and in M1582 (with sven0913 expressed from the ermE* promoter). (A) HPLC chromatogram of CHL
present in supernatants of 72 h culturesmeasured at a wavelength of 273 nm (seeMaterials andMethods). (B) CHL production, estimated as in panel A byHPLC
analysis, after 20, 48, and 72 h of culture. Bars indicate the standard deviation for three biological samples.
FIG 5 RT-PCR analysis of selected genes from the CHL biosynthetic gene
cluster. RNA was isolated from 16 h cultures of the S. venezuelae strains and
from 5-day cultures of the S. coelicolor M1152 derivatives and subjected to
RT-PCR analysis. Top, wild-type S. venezuelae and M1582 (with sven0913
expressed from the ermE* promoter [sven0913]). Bottom, S. coelicolor
M1581 and M1585 (with sven0913 deleted [sven0913]). The primer pairs
listed in Table S1 in the supplemental material were used. The numbers at the
top refer to the last two digits of the individual sven genes. A control (C)
without reverse transcriptase and using primers corresponding to sven0930
was used to confirm the absence of DNA contamination.
Chloramphenicol Production in Streptomyces venezuelae
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FIG 6 Revised pathway for CHL biosynthesis in S. venezuelae. SV_, protein designations from StrepDB (http://strepdb.streptomyces.org.uk/); those involved in
the shikimate pathway and not part of the CHL gene cluster are shown in blue.
Fernández-Martínez et al.
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ments (Fig. 5), which clearly demonstrate that sven0929 is tran-
scriptionally coregulated with genes involved in CHL
biosynthesis. However, the previous deletion of sven0929 (ORF13
of Piraee, White, and Vining [9]), which appears to encode an
aldo-keto reductase, had no apparent effect on CHL biosynthesis.
We believe that sven0929 is indeed part of the CHL biosynthetic
gene cluster and that its role in CHL biosynthesis, like that of
sven0914 and sven0915 in S. coelicolor, can be fulfilled by a func-
tional homologue located elsewhere in the S. venezuelae genome.
DISCUSSION
Newdevelopments in next-generation sequencing combinedwith
bioinformatic analysis greatly facilitate the comparison of genome
sequences of related bacteria. We have taken advantage of these
advances and combined themwithmicroarray analysis to identify
four new members of the CHL biosynthetic gene cluster:
sven0913, encoding a transcriptional activator; sven0914, encod-
ing a putative PPTase; sven0915, encoding a putative ion anti-
porter; and sven0925, encoding a putative ACP.
For reasons we do not understand, while the transcription of
the CHL biosynthetic gene cluster can be detected by microarray
analysis in our wild-type isolate of S. venezuelae (Fig. 1A), albeit at
a low level, we were unable to detect CHL production, despite
using a range of culture media. However, the constitutive expres-
sion of sven0913 resulted in readily detectable levels of antibiotic
production, further highlighting the value of ectopically express-
ing cluster-situated regulatory genes to activate natural product
biosynthesis (for an example, see reference 27).
The deletion of either sven0914 or sven0915, which appear to be
cotranscribed, decreasedCHLproduction by approximately 60%.
Production was restored to wild-type levels when each mutant
strain was complementedwith the respective gene, demonstrating
that the phenotype of the sven0914 mutant is not simply the
result of a polar effect of the deletion of sven0915 and that both
genes play a role in CHL production. Sven0914 is predicted to
encode a PPTase. PPTases are responsible for the conversion of
the inactive apo form of an ACP or peptidyl carrier protein (PCP)
to the active holo form by covalent attachment of a coenzyme-A-
derived phosphopantetheine group to a specific serine residue
(28). The posttranslational phosphopantetheinylation of the apo-
ACP/PCP domains is essential for the activities of many multien-
zyme synthases and synthetases responsible for the generation of a
variety of natural products, most notably polyketides and nonri-
bosomally synthesized peptides (29). Sven0914 contains all of the
conserved motifs found in the F/KES subfamily of Sfp-type
PPTases (30, 31). While many members of this subfamily utilize
PCPs as substrates, there are exceptions, most notably the
Sco6673-like PPTase of Streptomyces ambofaciens, which is able to
accept both ACP and PCP domains as substrates (32) and which
shares 53% amino acid sequence identity with Sven0914. Conse-
quently, we cannot reliably predict whether Sven0914 is involved
in the modification of the PCP domain of Sven0922 (see below),
the ACP Sven0929, or both.
Interestingly, not all natural products that require the activity
of a PPTase for their synthesis contain the corresponding gene
within their biosynthetic gene clusters, and instead, they utilize a
PPTase encoded elsewhere in the genome. Consequently, it is not
too surprising that the deletion of sven0914 reduced but did not
abolish CHL production. Indeed, the CHL biosynthetic gene clus-
ter of M. carbonacea ATCC 39149 (33) (GenBank accession no.
GG657738) lacks a sven0914 homologue, although all of the other
genes required for CHL production are present and arranged in
precisely the same manner as in S. venezuelae (see Fig. S3 in the
supplemental material). A BLASTp search to find the possible
homologues of Sven0914 in the heterologous host S. coelicolor
identified Sco6673, with 54% amino acid sequence identity. A
Pfam database search (34) identified a PPTase domain within the
C-terminal region of Sco6673 andmay explainwhy the deletion of
sven0914 still results in some CHL production in the heterologous
host (the Sco6673 and the Sco6673-like proteins of S. ambofaciens
share 83% identity).
sven0915 is predicted to encode an Na/H ion antiporter.
Divergently transcribed from sven0915 is sven0916, which is pre-
dicted to encode an efflux permease from the major facilitator
superfamily, and it is presumably involved in CHL export. These
efflux pumps are often involved in multidrug resistance, export-
ing toxic compounds to the outside of the cell, and they are usually
driven by the energy stored in ion gradients to catalyze the
transport of drugs across the membrane. Given their proximity
in the CHL gene cluster, it is conceivable that sven0915 pro-
vides the energy required for sven0916 to export CHL outside
the cell. The deletion of sven0915 reduced CHL production by
	60% in the heterologous host S. coelicolor. Several homologues
of sven0915 occur in the S. coelicolor M1152 genome, any one or
more of which may partially compensate for the loss of Sven0915,
thus allowing continued CHL export, although at lower levels, in
the deletion mutant.
Our studies have identified four new genes that play, or that are
likely to play, a role in CHL biosynthesis in S. venezuelae, prompt-
ing us to present an updated view of the CHL biosynthetic path-
way (Fig. 6 and Table 3). Although previous studies have some-
times used different nomenclatures to represent the same gene, we
have adopted that of Piraee, White, and Vining (9) to denote pre-
viously identified CHL biosynthetic genes, and we propose five
new cml designations: cmlR, cmlL, cmlN, and cmlM for the newly
identified genes described in this paper and cmlT for sven0929.
As previously noted, CHL biosynthesis utilizes the shikimate
pathway, which leads to chorismic acid and hence aromatic amino
acid production. Some of the chorismic acid is converted to
4-amino-4-deoxychorismate, which is used for synthesis of the
essential metabolite PABA. 4-Amino-4-deoxychorismate is also
utilized as the precursor for the pathway dedicated to CHL pro-
duction. BLASTp searches of the S. venezuelae proteome con-
firmed that genes encoding homologues of two of the primary
metabolic enzymes involved in 4-amino-4-deoxychorismate bio-
synthesis, 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate
(DAHP) synthase and 4-amino-4-deoxychorismate synthase,
were present in the cml gene cluster (sven0917 [cmlE] and
sven0920 [previously pabAB {9}, cmlB here], respectively. Homo-
logues of sven0917 and sven0920 are also located elsewhere in the
S. venezuelae genome and are presumably involved in primary
metabolism. DAHP synthesis is the first committed step of the
shikimate pathway and is often subject to feedback inhibition or
repression in other microorganisms (35). Our transcriptional
profiling suggests that CHL biosynthesis occurs at the end of rapid
vegetative growth in S. venezuelae, when proteolytic degradation
of existing proteins may provide an intracellular amino acid pool
for continued morphological development. Such a source of aro-
matic amino acids might act to inhibit the expression and/or ac-
tivity of the primary metabolic DAHP synthase and thus restrict
Chloramphenicol Production in Streptomyces venezuelae
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the precursor pool for CHL biosynthesis. We speculate that the
existence of a gene, cmlE, within theCHLbiosynthetic gene cluster
that encodes a DHAP synthase homologue may serve to ensure
sufficient flux through the shikimate pathway for sustained CHL
biosynthesis. Similarly, the presence of a 4-amino-4-deoxychoris-
mate synthase homologue, cmlB, in the CHL biosynthetic gene
clustermay act to direct flux toward CHL biosynthesis rather than
continued aromatic amino acid production.
The work reported in this paper extends previous studies that
led to an increasingly informed understanding of CHL produc-
tion in S. venezuelae (3–6, 9, 36), and it allows us to present a
consolidated and updated view of the CHL biosynthetic pathway
(Fig. 6 and Table 3). Although the functions of many genes can be
assigned with certainty or a high level of confidence, the roles of
those involved in the dichloroacetylation of the CHL precursor
remain obscure. Partly by a process of elimination, these genes are
likely to include sven0925 (cmlM), sven0926 (cmlJ), sven0927
(cmlK), and sven0929 (cmlT), as well as sven0928 (cmlS), encoding
a flavin-dependent halogenase. All five of these genes are clustered
together and may well be contained in a single operon, consistent
with a common function. Based on the similarity of CmlK to the
adenylating enzymes PchD and DhbE, which utilize salicylic acid
and 2,3-dihydroxybenzoic acid as substrates, respectively, Piraee,
White, and Vining (9) speculated that dichloroacetylation occurs
through CmlK-mediated adenylation of an aromatic carboxylic
acid. The recognition of the putative ACP CmlM in this study
suggests that CmlM may also be a substrate for CmlK, tethering
the carboxylic acid prior to halogenation (Fig. 6).
Surprisingly, microarray analyses revealed that the expression
of the CHL biosynthetic gene cluster was markedly enhanced in
bldM, whiI, bldN, and whiG (data not shown) mutants of S. ven-
ezuelae. BldM and WhiI are both orphan atypical response regu-
lators that play a crucial role in morphological differentiation.
Recent work has demonstrated that BldM and WhiI can form a
heterodimer that activates transcription from so-called group II
promoters, presumably integrating signals from two distinct de-
velopmental pathways (37). Chromatin immunoprecipitation se-
quencing (ChIP-Seq) analysis by the same authors failed to reveal
binding of either protein to any of the potential promoter regions
in the CHL biosynthetic gene cluster, nor did we find a sequence
motif corresponding to the consensus recognition sequence for
group II promoters anywhere in the gene cluster. It thus seems
unlikely that a BldM-WhiI heterodimer can directly repress CHL
gene expression in the wild-type strain. The elevated levels of CHL
gene transcription observed in both bldM and whiI mutants may
thus reflect the existence of an as-yet-unidentified gene that neg-
atively regulates CHL production and whose expression is depen-
dent on the BldM-WhiI heterodimer. bldM is transcribed from
two promoters, one of which (p1) is directly activated by BldN at
the onset of development (23, 38), and thus the effect of deleting
bldN on CHL gene transcription is presumably mediated through
decreased levels of bldM transcription. Similarly, the transcription
ofwhiI is activated from a singleWhiG-dependent promoter (39),
presumably explaining the effect of mutation ofwhiG on cml gene
transcription.
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